View in EDS

Erdafitinib in Patients with High- and Intermediate-risk Non-muscle-invasive Bladder Cancer: Final Analysis of THOR-2 Study.

Saved in:
Bibliographic Details
Title: Erdafitinib in Patients with High- and Intermediate-risk Non-muscle-invasive Bladder Cancer: Final Analysis of THOR-2 Study.
Authors: Daneshmand S; Department of Urology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA. Electronic address: daneshma@med.usc.edu., Zaucha R; Department of Clinical Oncology and Radiotherapy, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland., Catto JWF; Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK., Tran B; Department of Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia., Master V; Department of Urology, Emory University, Atlanta, GA, USA., Lotan Y; Department of Urology, UT Southwestern Medical Center, Dallas, TX, USA., Pignot G; Department of Surgical Oncology 2, Institut Paoli-Calmettes, Marseille, France., Tubaro A; Department of Urology, Sant'Andrea Hospital, Rome, Italy., Shimizu N; Department of Urology, Gunma Prefectural Cancer Center, Gunma, Japan., Vasdev N; Hertfordshire and Bedfordshire Urological Cancer Centre, Lister Hospital, East and North Herts NHS Trust, Stevenage, UK; School of Life and Medical Sciences, University of Hertford, Hatfield, UK., Lee EK; Department of Urology, University of Kansas Health System, Kansas City, KS, USA., Procopio G; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Galanternik F; Servicio de Oncología Clínica, Centro de Educación Médica e Investigaciones Clínicas, Buenos Aires, Argentina., Crow L; Johnson & Johnson Spring House, PA, USA., Deprince K; Johnson & Johnson, Beerse, Belgium., Naini V; Johnson & Johnson, San Diego, CA, USA., Triantos S; Johnson & Johnson, Raritan, NJ, USA., Baig M; Johnson & Johnson Spring House, PA, USA., Zhu W; Johnson & Johnson, Raritan, NJ, USA., Maranchie JK; Department of Urology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Source: European urology [Eur Urol] 2026 Feb; Vol. 89 (2), pp. 165-173. Date of Electronic Publication: 2025 Oct 07.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study
Journal Info: Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41062389
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Erdafitinib in Patients with High- and Intermediate-risk Non-muscle-invasive Bladder Cancer: Final Analysis of THOR-2 Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Daneshmand+S%22">Daneshmand S</searchLink>; Department of Urology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA. Electronic address: daneshma@med.usc.edu.<br /><searchLink fieldCode="AU" term="%22Zaucha+R%22">Zaucha R</searchLink>; Department of Clinical Oncology and Radiotherapy, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland.<br /><searchLink fieldCode="AU" term="%22Catto+JWF%22">Catto JWF</searchLink>; Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Tran+B%22">Tran B</searchLink>; Department of Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Master+V%22">Master V</searchLink>; Department of Urology, Emory University, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Lotan+Y%22">Lotan Y</searchLink>; Department of Urology, UT Southwestern Medical Center, Dallas, TX, USA.<br /><searchLink fieldCode="AU" term="%22Pignot+G%22">Pignot G</searchLink>; Department of Surgical Oncology 2, Institut Paoli-Calmettes, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Tubaro+A%22">Tubaro A</searchLink>; Department of Urology, Sant'Andrea Hospital, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Shimizu+N%22">Shimizu N</searchLink>; Department of Urology, Gunma Prefectural Cancer Center, Gunma, Japan.<br /><searchLink fieldCode="AU" term="%22Vasdev+N%22">Vasdev N</searchLink>; Hertfordshire and Bedfordshire Urological Cancer Centre, Lister Hospital, East and North Herts NHS Trust, Stevenage, UK; School of Life and Medical Sciences, University of Hertford, Hatfield, UK.<br /><searchLink fieldCode="AU" term="%22Lee+EK%22">Lee EK</searchLink>; Department of Urology, University of Kansas Health System, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Procopio+G%22">Procopio G</searchLink>; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Galanternik+F%22">Galanternik F</searchLink>; Servicio de Oncología Clínica, Centro de Educación Médica e Investigaciones Clínicas, Buenos Aires, Argentina.<br /><searchLink fieldCode="AU" term="%22Crow+L%22">Crow L</searchLink>; Johnson & Johnson Spring House, PA, USA.<br /><searchLink fieldCode="AU" term="%22Deprince+K%22">Deprince K</searchLink>; Johnson & Johnson, Beerse, Belgium.<br /><searchLink fieldCode="AU" term="%22Naini+V%22">Naini V</searchLink>; Johnson & Johnson, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Triantos+S%22">Triantos S</searchLink>; Johnson & Johnson, Raritan, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Baig+M%22">Baig M</searchLink>; Johnson & Johnson Spring House, PA, USA.<br /><searchLink fieldCode="AU" term="%22Zhu+W%22">Zhu W</searchLink>; Johnson & Johnson, Raritan, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Maranchie+JK%22">Maranchie JK</searchLink>; Department of Urology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227512719%22">European urology</searchLink> [Eur Urol] 2026 Feb; Vol. 89 (2), pp. 165-173. <i>Date of Electronic Publication: </i>2025 Oct 07.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>7512719 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-7560 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203022838%22">03022838 </searchLink><i>NLM ISO Abbreviation: </i>Eur Urol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41062389
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.eururo.2025.09.4152
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 165
    Titles:
      – TitleFull: Erdafitinib in Patients with High- and Intermediate-risk Non-muscle-invasive Bladder Cancer: Final Analysis of THOR-2 Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Daneshmand S
      – PersonEntity:
          Name:
            NameFull: Zaucha R
      – PersonEntity:
          Name:
            NameFull: Catto JWF
      – PersonEntity:
          Name:
            NameFull: Tran B
      – PersonEntity:
          Name:
            NameFull: Master V
      – PersonEntity:
          Name:
            NameFull: Lotan Y
      – PersonEntity:
          Name:
            NameFull: Pignot G
      – PersonEntity:
          Name:
            NameFull: Tubaro A
      – PersonEntity:
          Name:
            NameFull: Shimizu N
      – PersonEntity:
          Name:
            NameFull: Vasdev N
      – PersonEntity:
          Name:
            NameFull: Lee EK
      – PersonEntity:
          Name:
            NameFull: Procopio G
      – PersonEntity:
          Name:
            NameFull: Galanternik F
      – PersonEntity:
          Name:
            NameFull: Crow L
      – PersonEntity:
          Name:
            NameFull: Deprince K
      – PersonEntity:
          Name:
            NameFull: Naini V
      – PersonEntity:
          Name:
            NameFull: Triantos S
      – PersonEntity:
          Name:
            NameFull: Baig M
      – PersonEntity:
          Name:
            NameFull: Zhu W
      – PersonEntity:
          Name:
            NameFull: Maranchie JK
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2026 Feb
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1873-7560
          Numbering:
            – Type: volume
              Value: 89
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: European urology
              Type: main
ResultId 1